StonvexLoading…
StonvexStonvexStonvexCore line items from GRPN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $498.42M | $492.56M | $514.91M | $599.09M |
Operating Income | $23.64M | $8.79M | $-18.25M | $-167.81M |
Net Income | $-83.52M | $-59.03M | $-55.41M | $-237.61M |
EPS (Diluted) | $-2.08 | $-1.51 | $-1.77 | $-7.88 |
Total Assets | $670.41M | $612.69M | $570.96M | $793.12M |
Total Liabilities | $712.80M | $571.64M | $611.27M | $784.26M |
Cash & Equivalents | $296.08M | $228.84M | $141.56M | $281.28M |
Free Cash Flow OCF − CapEx | $49.87M | $40.56M | $-97.27M | $-172.16M |
Shares Outstanding | 40.73M | 39.80M | 31.85M | 30.49M |